Anti-mitotic therapies that target tubulin are effective and widely used in treating cancer, but they have limitations related to the role of tubulin in the cytoskeleton of normal cells.

Negative trials are important and may inform practice as much as positive trials. Paclitaxel-carboplatin–containing regimens are standard-of-care initial treatment for advanced endometrial cancer. The ...

in combination with CDK4/6 inhibitor ribociclib at the San Antonio Breast Cancer Symposium (SABCS 2024) being held December 10-13, 2024, at the Henry B. Gonzalez Convention Center in San Antonio ...

Vepdegestrant is being developed as a potential monotherapy and as part of combination therapy across multiple treatment settings for ER+/HER2- metastatic breast cancer. In July 2021, Arvinas ...

SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, ...

Submitted by the GoFundMe organizers. Our beloved island treasure, BooBoo, needs our help. Two months ago, she received some shocking news. Not only did she have kidney cancer, but she also has lung ...

Fazlur Rahman, who practiced oncology in San Angelo and is an adjunct professor at Angelo State University, has released a book about rural medicine. Rahman wrote "Our Connected Lives" for cancer ...

A new study on the effects that COVID-19 could potentially have on cancer tumors is causing a lot of buzz online. Northwestern University researchers found that the virus triggers immune changes that ...